VivoSim Labs (LTS:0R02) FFO


LTS:0R02 VivoSim Labs Inc LTS:0R02
38 GF Score
Price $3.17
GF Value $9.57
! 4 Warning Signs
View Full Analysis

What is VivoSim Labs FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0R02
38GF Score
VivoSim Labs Inc LTS:0R02
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is VivoSim Labs (LTS:0R02) Overvalued in 2026?

Based on GuruFocus' analysis, VivoSim Labs stock appears to be undervalued. The current stock price of $3.17 is trading 66.8% below its estimated GF Value™ of $9.57.

Key valuation signals for LTS:0R02:

  • FFO:
  • GF Value™: $9.57 vs. price of $3.17 (66.8% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R02 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

VivoSim Labs Business Description

Other Exchanges VIVS:USA
Address 11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
38GF Score

Get the complete analysis for LTS:0R02

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.17
Price
$9.57
GF Value